103 related articles for article (PubMed ID: 3216222)
1. Inhibition of the growth of Lewis lung carcinoma by indomethacin in conventional, nude, and beige mice.
Maca RD
J Biol Response Mod; 1988 Dec; 7(6):568-80. PubMed ID: 3216222
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of etoposide and methotrexate sensitivity by indomethacin in vitro.
Maca RD
Anticancer Drug Des; 1991 Nov; 6(5):453-66. PubMed ID: 1722410
[TBL] [Abstract][Full Text] [Related]
3. Effect of prostaglandin E2-producing nonmetastatic Lewis lung carcinoma cells on the migration of prostaglandin E2-responsive metastatic Lewis lung carcinoma cells.
Young MR; Young ME; Wepsic HT
Cancer Res; 1987 Jul; 47(14):3679-83. PubMed ID: 3109729
[TBL] [Abstract][Full Text] [Related]
4. Association of a functional prostaglandin E2-protein kinase A coupling with responsiveness of metastatic Lewis lung carcinoma variants to prostaglandin E2 and to prostaglandin E2-producing nonmetastatic Lewis lung carcinoma variants.
Young MR; Duffie GP; Lozano Y; Young ME; Wright MA
Cancer Res; 1990 May; 50(10):2973-8. PubMed ID: 2159367
[TBL] [Abstract][Full Text] [Related]
5. Regulation of tumor-induced myelopoiesis and the associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma by prostaglandin E2.
Young MR; Young ME; Kim K
Cancer Res; 1988 Dec; 48(23):6826-31. PubMed ID: 2972359
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin E production by Lewis lung carcinoma: mechanism for tumor establishment in vivo.
Young MR; Knies S
J Natl Cancer Inst; 1984 Apr; 72(4):919-22. PubMed ID: 6584667
[TBL] [Abstract][Full Text] [Related]
7. Antitumor and antimetastatic activities of 4-hydroxyderricin isolated from Angelica keiskei roots.
Kimura Y; Taniguchi M; Baba K
Planta Med; 2004 Mar; 70(3):211-9. PubMed ID: 15114497
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of spleen cell cytotoxic capacity toward tumor by elevated prostaglandin E2 levels in mice bearing Lewis lung carcinoma.
Young MR; Hoover CS
J Natl Cancer Inst; 1986 Aug; 77(2):425-9. PubMed ID: 2942724
[TBL] [Abstract][Full Text] [Related]
9. The inhibitory effects of prostaglandin E1 and indomethacin on the growth and metastasis of transplanted Lewis lung carcinoma in C57BL mice.
Tang DG; Tian HS
Chin Med J (Engl); 1990 Mar; 103(3):208-15. PubMed ID: 2164465
[TBL] [Abstract][Full Text] [Related]
10. Interactions in the tumor-promoting activity of carbon tetrachloride, trichloroacetate, and dichloroacetate in the liver of male B6C3F1 mice.
Bull RJ; Sasser LB; Lei XC
Toxicology; 2004 Jul; 199(2-3):169-83. PubMed ID: 15147791
[TBL] [Abstract][Full Text] [Related]
11. Effects of alpha-difluoromethylornithine and recombinant interferon-alpha 2 on the growth of a human renal cell adenocarcinoma xenograft in nude mice.
Heston WD; Fleischmann J; Tackett RE; Ratliff TL
Cancer Res; 1984 Aug; 44(8):3220-5. PubMed ID: 6430546
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effect of bcl-2 antisense oligodeoxynucleotides on growth of human lung carcinoma xenograft in nude mice].
He DM; Zhang H
Ai Zheng; 2006 Jan; 25(1):40-4. PubMed ID: 16405747
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the growth of various human and mouse tumor cells by 1,15-bis(ethylamino)-4,8,12-triazapentadecane.
Igarashi K; Koga K; He Y; Shimogori T; Ekimoto H; Kashiwagi K; Shirahata A
Cancer Res; 1995 Jun; 55(12):2615-9. PubMed ID: 7780977
[TBL] [Abstract][Full Text] [Related]
14. [Anti-cancer treatment with prostaglandin synthetase inhibitor in animal models].
Narisawa T; Takahashi M; Masuda T; Nagasawa O; Ogata N; Niwa M
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1329-35. PubMed ID: 3089171
[TBL] [Abstract][Full Text] [Related]
15. [Inhibition of growth and metastasis of Lewis lung carcinoma in C57BL mice immunized with PGE2-bovine thyroglobulin conjugate].
Li W
Zhonghua Zhong Liu Za Zhi; 1992 Nov; 13(6):427-9. PubMed ID: 1576908
[TBL] [Abstract][Full Text] [Related]
16. In vivo effects of indomethacin on the growth of murine mammary tumors.
Fulton AM
Cancer Res; 1984 Jun; 44(6):2416-20. PubMed ID: 6722783
[TBL] [Abstract][Full Text] [Related]
17. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of Lewis lung carcinoma cell migration by prostaglandin E2 produced by macrophages.
Young MR; Newby M
Cancer Res; 1986 Jan; 46(1):160-4. PubMed ID: 3455665
[TBL] [Abstract][Full Text] [Related]
19. Differential induction of suppressor macrophages by cloned Lewis lung carcinoma variants in mice.
Young MR; Newby M
J Natl Cancer Inst; 1986 Dec; 77(6):1255-60. PubMed ID: 3491925
[TBL] [Abstract][Full Text] [Related]
20. Local inhibition of natural killer cell activity promotes the progressive growth of intraocular tumors.
Apte RS; Mayhew E; Niederkorn JY
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1277-82. PubMed ID: 9152248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
